Table 2.
Clinical Characteristics for HIV Positive participants
| HIV Positive (n=67) | |||
|---|---|---|---|
| (Mean ± SD or n (%)) | HCV Negative (n=21) |
HCV Positive (n=46) |
P-Value |
| CD4 absolute (1) | 211 ± 166 | 257 ± 168 | 0.31 |
| Viral load (copies/ml) (1) | 327,257 ± 284,442 | 71,417 ± 140,351 | 0.001 |
| Viral load suppressed (<400 Copies) (1) | 0 (0%) | 13 (29%) | 0.007* |
| HAART treatment (1) | 3 (14%) | 21 (47%) | 0.01 |
| Efavirenz (1) | 2 (10%) | 8 (18%) | 0.48* |
| Nevirapine (1) | 0 (0%) | 3 (7%) | 0.55* |
| Ritonavir and/or Kaletra (1) | 1 (5%) | 9 (20%) | 0.15* |
Fisher’s Exact test used because 25% or more of cells had expected counts less than 5.0
HAART missing data for one participant. CD4 and Viral load missing data for three participants